Diamonds and Dogs

June 19th, 2014

Diamond: StemCells, Inc. (STEM)

The Biotechnology remains in the spotlight today as the diamond for the day is StemCell, Inc. The StemCell therapeutics developer had positive results from its Phase I/II clinical trial for a neural stem cell platform. The platform is used for age-related macular degeneration. Tests resulted in improvement in visual function and slowed the progression of the disease. A 70% decrease in the rate of retinal tissue was a great result from the trial, and Maxim Group even stated that these results "could be transformational for the company." StemCell's stock price rose more than 30% on the news to a 52-week high of 2.10. Maxim Group's coverage of the company states that the company is a "buy" with a price target of $2.50.

Dog: Pier 1 Imports, Inc. (PIR)

The dog of the day is the home furnishing retailer, Pier 1 Imports Inc. The company reported below-consensus earnings for the quarter along with poor guidance for FY15. Before the morning bell, Pier 1 reported EPS of 16 cents a share compared to the analyst estimate of 20 cents. Along with this, the company announced revenues $3 million below the expectations. If this wasn't enough, management lowered earnings guidance to between $1.14 and $1.22 for the fiscal year of 2015. The price of the company's stock finished the day down approximately %13 and hit a 52-week low of 15.70. Investors are now waiting to see a boost in sales, hopefully fueling a comeback from this relatively strong stock.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.